CRP and atherosclerosis: Accordingly, in this study, we evaluated the effects of mutant CRP (F66A/T76Y/E81A) on the development of atherosclerosis employing LDL receptor-deficient (Ldlr−/−) mice, an animal model commonly used to investigate molecules involved in human atherosclerosis.